Detection of transcriptomic changes in N9 and N33 GBM cells following treatment with small molecular inhibitors of MK-0752, WP1066 and retinoic acid
RNA-seq (gene expression) · human · 18 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- GlioblastomaThis series is part of our curated briefing on it.
- Samples
- 18 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE324741_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1436942 and SRA study SRP683356. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 18 samples.
How we read this: 6 replicated groups read from 18 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9584666 N9 cells, CONT, 48h, rep1 N9 cells, CONT, 48h,
- GSM9584667 N9 cells, CONT, 48h, rep2 N9 cells, CONT, 48h,
- GSM9584668 N9 cells, CONT, 48h, rep3 N9 cells, CONT, 48h,
- GSM9584669 N9 cells, treated with MK+WP, 48h, rep1 N9 cells, treated with …
- GSM9584670 N9 cells, treated with MK+WP, 48h, rep2 N9 cells, treated with …
- GSM9584671 N9 cells, treated with MK+WP, 48h, rep3 N9 cells, treated with …
- GSM9584672 N9 cells, treated with MK+WP+RA, 48h, rep1 N9 cells, treated with …
- GSM9584673 N9 cells, treated with MK+WP+RA, 48h, rep2 N9 cells, treated with …
- GSM9584674 N9 cells, treated with MK+WP+RA, 48h, rep3 N9 cells, treated with …
- GSM9584675 N33 cells, CONT, 48h, rep1 N33 cells, CONT, 48h,
- GSM9584676 N33 cells, CONT, 48h, rep2 N33 cells, CONT, 48h,
- GSM9584677 N33 cells, CONT, 48h, rep3 N33 cells, CONT, 48h,
- GSM9584678 N33 cells, treated with MK+WP, 48h, rep1 N33 cells, treated with…
- GSM9584679 N33 cells, treated with MK+WP, 48h, rep2 N33 cells, treated with…
- GSM9584680 N33 cells, treated with MK+WP, 48h, rep3 N33 cells, treated with…
- GSM9584681 N33 cells, treated with MK+WP+RA, 48h, rep1 N33 cells, treated with…
- GSM9584682 N33 cells, treated with MK+WP+RA, 48h, rep2 N33 cells, treated with…
- GSM9584683 N33 cells, treated with MK+WP+RA, 48h, rep3 N33 cells, treated with…
- GSE122283 H3K27ac ChIP-seq in GBM cell lines SF763 PTEN-KO and U87 4 samples same disease briefing · shares gbm
- GSE231555 Splicing and gene expression changes in cell lines treated with splicing switching oligonucleotide targeting TRA2B 46 samples same disease briefing
- GSE112648 SOXC factors as suppressors modulate Rho activity to promote neuronal reprogramming of human glioblastoma cells 18 samples same disease briefing
- GSE131928 single cell RNA-seq analysis of adult and paediatric IDH-wildtype Glioblastomas 2 samples same disease briefing
- GSE107560 Ivy Glioblastoma Atlas Project 305 samples same disease briefing
- GSE13041 Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age 267 samples same disease briefing
- GSE10878 Integrative Genome-wide Analysis of Glioblastoma. 60 samples same disease briefing
- GSE112650 SOX4/11 Enhances NGN2 Reprogramming Glioblastoma Cells into Neuron Cells by Modulating RhoA and CDC42/RAC1 Pathway Activity 30 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.